NIH-funded research NIH-funded research

Gene clues that help DM1 muscle disease age and treatment answers

Official title: Genome Wide Association Study

Funded at Virginia Commonwealth University · NIH-11423684 · Data updated 2026-11-12

A large NIH grant will study how DNA repair and RNA splicing genes influence when DM1 symptoms start and how patients respond to treatments.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVirginia Commonwealth University
NIH-funded
Lab location1 site (Richmond, United States)
Project startSeptember 25, 2025
Project endAugust 31, 2030
Funding year2026
Award (this year)$402,907
NIH project number5P50AR085906-02
Project IDNIH-11423684 on NIH RePORTER

Who could benefit from this research

Could help

People with DM1 who have known CTG repeat expansions and available genetic and clinical data from prior studies.

Less likely to help

Patients not matching DM1 criteria or without access to the relevant genetic data may not benefit.

What this research studies

This project focuses on myotonic dystrophy type 1 (DM1), a muscular disease with heart and cognitive effects, and looks at how genetic differences in DNA repair and RNA splicing may change when symptoms begin and how well therapies work. Researchers will use genetic data from multiple long-term studies to understand why two people with similar CTG repeats can have different disease courses. The team will examine variants in DNA repair pathways and RNA splicing proteins to see if they help explain variability beyond repeat length. The work involves analyzing human participant data and existing patient samples to find markers that predict onset and treatment response.

Why it matters

Potential benefit: If successful, patients could receive more personalized forecasts of disease progression and more tailored treatment options.

How similar studies have gone: Previous studies have suggested genetic modifiers influence DM1 severity and therapy response, supporting this approach.

Where this research is happening

  • Virginia Commonwealth University
    Richmond, United States
    Active

Researchers

  • Principal investigator: Johnson, Nicholas Elwood — Virginia Commonwealth University
  • Study coordinator: Johnson, Nicholas Elwood

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.